U.S. Agencies Seek Balance In Biotechnology Rules

WASHINGTON-Government agencies, in their zeal to demonstrate support for biotechnology research, may have unintentionally complicated efforts to regulate the burgeoning field, according to federal officials. "We have opened up a complex regulatory world that need not have been," asserted David Kingsbury of the National Science Foundation. There is a growing "tendency to 'do' all of biology," he added, as conscientious regulators "examine things that have been going on for long periods of time. W

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON-Government agencies, in their zeal to demonstrate support for biotechnology research, may have unintentionally complicated efforts to regulate the burgeoning field, according to federal officials.

"We have opened up a complex regulatory world that need not have been," asserted David Kingsbury of the National Science Foundation. There is a growing "tendency to 'do' all of biology," he added, as conscientious regulators "examine things that have been going on for long periods of time. We may have done ourselves some mischief."

Kingsbury, associate director for biological, behavioral and social sciences at the science foundation, also chairs the committee that is overseeing the federal effort to co ordinate biotechnology regulations and guidelines. He spoke during a one-day workshop last month on public funding of biotechnology research and training convened by the Office of Technology Assessment.

The various agencies involved in supporting biotechnology found themselves in a dilemma as interest in the subject ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Fox

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours